Clinical Trials in Los Angeles

Showing 10101-10120 of 14,465 trials

Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

NCT00459108

This phase II trial is studying how well dasatinib works in treating patients with advanced liver cancer that cannot be removed by surgery. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer

National Cancer Institute (NCI)25 participantsStarted Apr 2007

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Fosamprenavir Versus Other Protease Inhibitors

NCT00094523

This study was designed to evaluate and compare safety, tolerability of subjects who successfully suppress HIV-1 on their first PI regimen to those who switch to fosamprenavir. This is a 48-week study, where subjects who were assigned to be in their original PI-group have the option of switching to fosamprenavir on week 24. Prior to being assigned their treatment group, subjects had to be suppressed for at least three months. All subjects also take a background regimen of two nucleoside/nucleotide reverse transcriptase inhibitors.

Infection, Human Immunodeficiency Virus I

ViiV Healthcare314 participantsStarted Dec 2004

Beverly Hills, California, United States • Fresno, California, United States • Laguna Beach, California, United States +49 more locations

Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

Fosamprenavir Versus Other Protease Inhibitors

Find Trials by Condition in Los Angeles

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Maintenance of Shoulder Health and Function After Spinal Cord Injury

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

PXD101 in Treating Patients With Acute Myeloid Leukemia

Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis

A Study in Participants With Type 2 Diabetes Mellitus

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

A Study for Patients With Type 1 Diabetes

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting